Derivatives of betulin
AssigneeGlaxoSmithKline LLC
InventorBrian Alvin Johns
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds characterized by having a structure according to the following Formula I: or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.
Claims10
A compound of the structure:
- or a pharmaceutical acceptable salt thereof.
A compound of the structure:
A pharmaceutically acceptable salt of a compound of the structure:
A pharmaceutical composition comprising a compound of the structure:
- together with at least one pharmaceutically acceptable excipient.
A pharmaceutical composition comprising a compound of the structure:
- or a pharmaceutically acceptable salt thereof, together with at least one pharmaceutically acceptable excipient.
A compound of the structure:
- or a pharmaceutically acceptable salt thereof.
A compound of the structure:
A pharmaceutically acceptable salt of a compound of the structure:
A pharmaceutical composition comprising a compound of the structure:
- together with at least one pharmaceutically acceptable excipient.
A pharmaceutical composition comprising a compound of the structure:
- or a pharmaceutically acceptable salt thereof, together with at least one pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.